4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000172
Chairperson & CEO sold 9,500 shares at an average $588.64 ($5,592,095)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-26 | Sale : show line 2 in the form 10b5-1 | −600 | $585.71 | $351,427 | 333,343 | I |
| 2026-10-26 | Sale : show line 3 in the form 10b5-1 | −1,492 | $586.54 | $875,124 | 331,851 | I |
| 2026-10-26 | Sale : show line 4 in the form 10b5-1 | −2,707 | $587.54 | $1,590,474 | 329,144 | I |
| 2026-10-26 | Sale : show line 5 in the form 10b5-1 | −1,241 | $588.47 | $730,285 | 327,903 | I |
| 2026-10-26 | Sale : show line 6 in the form 10b5-1 | −1,280 | $589.64 | $754,736 | 326,623 | I |
| 2026-10-26 | Sale : show line 7 in the form 10b5-1 | −680 | $590.57 | $401,585 | 325,943 | I |
| 2026-10-26 | Sale : show line 8 in the form 10b5-1 | −694 | $591.60 | $410,570 | 325,249 | I |
| 2026-10-26 | Sale : show line 9 in the form 10b5-1 | −806 | $592.92 | $477,891 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $588.64 · $5,592,095 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-26 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option | −9,500 | 157,410 | I |
Loading xslF345X06/primarydocument.xml…